¿Qué hay de nuevo en el síndrome de ovario poliquístico? / Whats new in polycystic ovary syndrome
Rev. chil. endocrinol. diabetes
;
6(2): 69-75, abr. 2013. ilus
Article
in Spanish
| LILACS
| ID: lil-726577
ABSTRACT
Polycystic ovary syndrome is recognized as a risk factor for the development of type 2 diabetes and metabolic syndrome. The prevalence of the condition is 6 to 10 percent in different populations. Its etiology is not well known and there are genetic and epigenetic phenomena involved. Due to its association with insulin resistance, it has been incorporated as another component of Reaven plurimetabolic syndrome. Therefore polycystic ovary syndrome evolved from an ovarian disease to a multisystem disorder and it must be considered a public health problem.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Polycystic Ovary Syndrome
Type of study:
Risk factors
Limits:
Female
/
Humans
Language:
Spanish
Journal:
Rev. chil. endocrinol. diabetes
Journal subject:
Endocrinology
Year:
2013
Type:
Article
/
Project document
Affiliation country:
Chile
Institution/Affiliation country:
Hospital San Juan de Dios/CL
/
Universidad de Chile/CL
Similar
MEDLINE
...
LILACS
LIS